Brief: Health Holland Awards Innovative Research Grant For DNA Pol IIIC Inhibitors To Leiden University Medical Center
02/08/2021 13:19
Aug 2 (Reuters) - Acurx Pharmaceuticals Inc ACXP.O :
* HEALTH HOLLAND AWARDS INNOVATIVE RESEARCH GRANT FOR DNA
POL IIIC
INHIBITORS TO LEIDEN UNIVERSITY MEDICAL CENTER AND ACURX
PHARMACEUTICALS
Source text for Eikon: ID:nPn20cTxta
Further company coverage: ACXP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Acurx Pharmaceuticals
See all newsBrief: Acurx Pharmaceuticals Receives FDA Conditional Acceptance
Acurx Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Acurx Pharmaceuticals Q2 loss widens on higher R&D costs
Acurx Pharmaceuticals Inc expected to post a loss of 38 cents a share - Earnings Preview
Brief: FDA Provides Further Regulatory Guidance To Acurx Pharmaceuticals For The Ibezapolstat Clinical Development Program